Neuland Laboratories Limited (NSE: NEULANDLAB)

Market Cap	190.71B
Revenue (ttm)	15.28B
Net Income (ttm)	2.80B
Shares Out	n/a
EPS (ttm)	217.98
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 12, 2024

Volume	20,627
Open	14,880
Previous Close	14,889
Day's Range	14,713 - 15,480
52-Week Range	4,926 - 16,561
Beta	0.99
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 1,643
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NEULANDLAB

Financial Performance

In 2023, Neuland Laboratories's revenue was 15.59 billion, an increase of 30.81% compared to the previous year's 11.91 billion. Earnings were 3.00 billion, an increase of 83.51%.